Observations placeholder
Bidil or BiDil
Identifier
018045
Type of Spiritual Experience
Background
A description of the experience
Isosorbide dinitrate/hydralazine is a fixed dose combination drug treatment specifically indicated for African Americans with congestive heart failure. It is a combination of hydralazine (an antihypertensive) and isosorbide dinitrate (a vasodilator). It is the first race-based prescription drug in the United States.
The combination preparation is marketed in the United States under the trade name BiDil
On Oct, 6, 2015: 96 people reported to have side effects when taking Bidil. Among them, 2 people (2.08%) have Hallucination.
On Sep, 23, 2015: 96 people reported to have side effects when taking Bidil. Among them, 4 people (4.17%) have Death.
The source of the experience
eHealthmeConcepts, symbols and science items
Concepts
Symbols
Science Items
Activities and commonsteps
Activities
Overloads
AntihypertensivesHeart failure and coronary heart disease
Hypertension
Vasodilators